Phytopharm to acquire IXICO - MarketLine Financial Deals

Phytopharm to acquire IXICO

Phytopharm to acquire IXICO - MarketLine Financial Deals
Phytopharm to acquire IXICO
Published Sep 23, 2013
2 pages — Published Sep 23, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Phytopharm Plc, a pharmaceutical company, has agreed to acquire IXICO, Ltd., a medical technology and diagnostics company, for a consideration of approximately GBP5.6 million.

  
Source:
Document ID
MA142259_130930
Country
Ticker
PYM=GB
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Phytopharm to acquire IXICO" Sep 23, 2013. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Phytopharm-to-acquire-IXICO-2052-97891>
  
APA:
MarketLine Financial Deals. (2013). Phytopharm to acquire IXICO Sep 23, 2013. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Phytopharm-to-acquire-IXICO-2052-97891>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.